Danaher appoints Greg Milosevich to Executive Vice President, Life Sciences

Core Viewpoint - Danaher Corporation has appointed Greg Milosevich as Executive Vice President responsible for its Life Sciences business, effective July 1, 2025, highlighting the company's commitment to leadership continuity and growth in this sector [1][2]. Company Overview - Danaher Corporation is a leading global innovator in life sciences and diagnostics, focused on improving human health through advanced science and technology [4]. - The company employs approximately 63,000 associates worldwide, dedicated to solving significant health challenges and enhancing the quality of life for billions of people [4]. Leadership Appointment - Greg Milosevich has been with Danaher since 2010 and has held various roles, most recently as Vice President and Group Executive of the Life Sciences Innovations Group since 2021 [2][3]. - His appointment as Executive Vice President is seen as a strategic move to leverage his experience and results-driven approach to further advance Danaher's Life Sciences business [3]. Business Impact - Milosevich's leadership is expected to drive continued success in the Life Sciences sector, which includes overseeing multiple Danaher companies such as Beckman Coulter Life Sciences and Sciex [3].